The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide ID: ALA4740522
PubChem CID: 141755657
Max Phase: Preclinical
Molecular Formula: C24H23N3O2
Molecular Weight: 385.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2[nH]cc(CCNC(=O)c3ccccc3Nc3ccccc3)c2c1
Standard InChI: InChI=1S/C24H23N3O2/c1-29-19-11-12-22-21(15-19)17(16-26-22)13-14-25-24(28)20-9-5-6-10-23(20)27-18-7-3-2-4-8-18/h2-12,15-16,26-27H,13-14H2,1H3,(H,25,28)
Standard InChI Key: MALXHVGKGSHLTJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
3.5898 -3.2579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5886 -4.0851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3033 -4.4979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3015 -2.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0168 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0216 -4.0805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8090 -4.3313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2908 -3.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8012 -2.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0514 -2.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8572 -2.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4128 -2.6418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2186 -2.4656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7742 -3.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4689 -1.6797 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5207 -3.8606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0755 -4.4701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8823 -4.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1313 -3.5032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5749 -2.8972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7145 -4.0351 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4626 -4.8205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6548 -4.9914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4028 -5.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9573 -6.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7670 -6.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0154 -5.4256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8752 -2.8455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1609 -3.2582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
16 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
1 28 1 0
28 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.47Molecular Weight (Monoisotopic): 385.1790AlogP: 4.89#Rotatable Bonds: 7Polar Surface Area: 66.15Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.74CX LogD: 5.74Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -0.94
References 1. Fan X,Li J,Deng X,Lu Y,Feng Y,Ma S,Wen H,Zhao Q,Tan W,Shi T,Wang Z. (2020) Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation., 193 [PMID:32182488 ] [10.1016/j.ejmech.2020.112217 ] 2. Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, Hu X, Shi T, Tan W, Wang Z.. (2021) Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3., 211 [PMID:33248852 ] [10.1016/j.ejmech.2020.113027 ]